Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: A comparative cohort study - Université de Rennes Accéder directement au contenu
Article Dans Une Revue PLoS ONE Année : 2021

Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: A comparative cohort study

Résumé

INTRODUCTION: Evacuation of infected fluid in pleural infections is essential. To date, the use of an intrapleural fibrinolytic agent such as urokinase and DNase has not yet been assessed in infections managed by repeated therapeutic thoracentesis (RTT). METHODS: We performed a retrospective comparative study of two successive cohorts of consecutive patients with pleural infections from 2001 to 2018. Between 2001 and 2010, patients had RTT with intrapleural urokinase (RTT-U). After 2011, patients received intrapleural urokinase and DNase with RTT (RTT-UD). Data were collected through a standardized questionnaire. RESULTS: One hundred and thirty-three patients were included: 93 were men and the mean age was 59 years (standard deviation 17.2). Eighty-one patients were treated with a combination of intrapleural urokinase and DNase, and 52 were treated with intrapleural urokinase only. In the RTT-UD, RTT failure occurred in 14 patients (17%) compared to 10 (19%) in the RTT-U group (P = 0.82). There was no difference between the two groups in intensive care unit admission, surgical referrals or in-hospital mortality. RTT-UD was associated with faster time to apyrexia (aOR = 0.51, 95%CI [0.37-0.72]), a reduced length of hospital stay (aOR = 0.61, 95%CI [0.52-0.73]) and a higher volume of total pleural fluid retrieved (aOR = 1.38, 95%CI [1.02-1.88]). Complications were rare with only one hemothorax in the RTT-UD group and no pneumothorax requiring drainage in either group. CONCLUSION: Compared to urokinase only, intrapleural use of urokinase and DNase in RTT was associated with quicker defervescence, shorter hospital stay and increased volumes of pleural fluid drained. Randomized controlled trials evaluating urokinase and DNase with RTT technique would be required to confirm these results.
Fichier principal
Vignette du fichier
journal.pone.0257339.pdf (836.92 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03369824 , version 1 (07-10-2021)

Licence

Paternité

Identifiants

Citer

David Luque Paz, Betsega Bayeh, Pierre Chauvin, Florence Poizeau, Mathieu Lederlin, et al.. Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: A comparative cohort study. PLoS ONE, 2021, 16 (9), pp.e0257339. ⟨10.1371/journal.pone.0257339⟩. ⟨hal-03369824⟩
100 Consultations
46 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More